JHS — JHS Svendgaard Laboratories Income Statement
0.000.00%
Last trade - 00:00
- IN₹1.38bn
- IN₹1.33bn
- IN₹962.07m
- 34
- 32
- 33
- 19
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,241 | 1,391 | 1,008 | 863 | 962 |
Cost of Revenue | |||||
Gross Profit | 322 | 340 | 271 | 209 | 232 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,310 | 1,461 | 1,061 | 941 | 1,314 |
Operating Profit | -69.3 | -69.8 | -52.9 | -78.9 | -352 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -20.4 | -58.4 | 9.68 | 1.03 | -218 |
Provision for Income Taxes | |||||
Net Income After Taxes | -16.7 | -48.5 | 13.4 | -42.9 | -168 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -6.81 | -19.8 | 12 | -40.5 | -155 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -6.81 | -19.8 | 12 | -40.5 | -155 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.038 | 0.808 | 0.201 | -0.624 | -0.517 |